Abdominal Imaging Division, Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto, Toronto, Canada.
Clin Imaging. 2011 Mar-Apr;35(2):127-32. doi: 10.1016/j.clinimag.2010.03.003.
The purpose of this study was to assess the potential role for chemical shift magnetic resonance imaging (MRI) in identifying lymphangiomas from other cystic mesenteric and retroperitoneal masses.
A retrospective search of radiology database identified 24 consecutive patients with mesenteric and retroperitoneal cysts (nine men, 15 women; mean age, 41 years; age range, 19-75 years) who had undergone MR which included in-phase and opposed-phase chemical shift imaging. Signal intensity (SI) decrease between in-phase and opposed-phase MR images of the cyst was evaluated qualitatively by two radiologists. Ultrasound (US), computed tomography (CT), and MRI findings of the morphological appearances of all the cystic lesions that demonstrated significant signal drop on chemical shift MR were also recorded.
Of mesenteric and retroperitoneal cysts, 33% (8/24) revealed qualitative decrease in intensity on opposed-phase MR images relative to that seen on in-phase images. On ultrasound, these cysts demonstrated anechoic simple fluid. Their mean CT attenuation was 13 HU (range: 5-20 HU). Signal loss on fat-suppressed T1-weighted sequences was displayed only by a single cyst. None of the lesions with qualitative SI decrease on opposed-phase MR showed suggestion of lipid on US and CT.
The presence of intra cystic lipid detected by chemical shift MR may not be overt on cross-sectional imaging such as US and CT. Chemical shift MRI provides additional sensitivity and specificity as an imaging test for demonstration of lipid within mesenteric and retroperitoneal cysts enabling a higher diagnostic yield for lymphangioma leading to more appropriate patient management.
本研究旨在评估化学位移磁共振成像(MRI)在识别淋巴管瘤与其他囊性肠系膜和腹膜后肿块中的潜在作用。
对放射学数据库进行回顾性检索,确定了 24 例肠系膜和腹膜后囊肿患者(9 名男性,15 名女性;平均年龄 41 岁;年龄范围 19-75 岁),这些患者均接受了包括同相位和反相位化学位移成像在内的 MRI 检查。两位放射科医生对囊肿的同相位和反相位 MRI 图像之间的信号强度(SI)下降进行定性评估。还记录了所有囊性病变的超声(US)、计算机断层扫描(CT)和 MRI 形态学表现,这些病变在化学位移 MRI 上显示出明显的信号下降。
肠系膜和腹膜后囊肿中,33%(8/24)在反相位 MRI 图像上相对于同相位图像显示出强度的定性下降。在超声上,这些囊肿表现为无回声单纯性液体。它们的平均 CT 衰减值为 13 HU(范围:5-20 HU)。仅一个囊肿在脂肪抑制 T1 加权序列上显示信号丢失。在反相位 MRI 上具有定性 SI 下降的病变在 US 和 CT 上均未显示脂质的提示。
化学位移 MRI 检测到的囊内脂质可能在 US 和 CT 等横截面成像上并不明显。化学位移 MRI 作为一种影像学检查,提供了更高的敏感性和特异性,可用于显示肠系膜和腹膜后囊肿内的脂质,从而提高淋巴管瘤的诊断率,从而为患者提供更恰当的管理。